HEADER HYDROLASE 10-DEC-96 1HPO TITLE HIV-1 PROTEASE TRIPLE MUTANT/U103265 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE; COMPND 5 EC: 3.4.23.16; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HYDROLASE, ACID PROTEASE, ASPARTYL PROTEASE EXPDTA X-RAY DIFFRACTION AUTHOR K.D.WATENPAUGH,M.N.JANAKIRAMAN REVDAT 7 07-FEB-24 1HPO 1 REMARK REVDAT 6 03-NOV-21 1HPO 1 REMARK SEQADV REVDAT 5 07-MAR-18 1HPO 1 REMARK REVDAT 4 22-FEB-12 1HPO 1 JRNL VERSN REVDAT 3 24-FEB-09 1HPO 1 VERSN REVDAT 2 01-APR-03 1HPO 1 JRNL REVDAT 1 21-APR-97 1HPO 0 JRNL AUTH H.I.SKULNICK,P.D.JOHNSON,P.A.ARISTOFF,J.K.MORRIS,K.D.LOVASZ, JRNL AUTH 2 W.J.HOWE,K.D.WATENPAUGH,M.N.JANAKIRAMAN,D.J.ANDERSON, JRNL AUTH 3 R.J.REISCHER,T.M.SCHWARTZ,L.S.BANITT,P.K.TOMICH,J.C.LYNN, JRNL AUTH 4 M.M.HORNG,K.T.CHONG,R.R.HINSHAW,L.A.DOLAK,E.P.SEEST, JRNL AUTH 5 F.J.SCHWENDE,B.D.RUSH,G.M.HOWARD,L.N.TOTH,K.R.WILKINSON, JRNL AUTH 6 T.J.KAKUK,C.W.JOHNSON,S.L.COLE,R.M.ZAYA,G.L.ZIPP, JRNL AUTH 7 P.L.POSSERT,R.J.DALGA,W.-Z.ZHONG,M.G.WILLIAMS,K.R.ROMINES JRNL TITL STRUCTURE-BASED DESIGN OF NONPEPTIDIC HIV PROTEASE JRNL TITL 2 INHIBITORS: THE SULFONAMIDE-SUBSTITUTED CYCLOOCTYLPYRAMONES. JRNL REF J.MED.CHEM. V. 40 1149 1997 JRNL REFN ISSN 0022-2623 JRNL PMID 9089336 JRNL DOI 10.1021/JM960441M REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.I.SKULNICK,P.D.JOHNSON,W.J.HOWE,P.K.TOMICH,K.T.CHONG, REMARK 1 AUTH 2 K.D.WATENPAUGH,M.N.JANAKIRAMAN,L.A.DOLAK,J.P.MCGRATH, REMARK 1 AUTH 3 J.C.LYNN,M.-M.HORNG,R.B.HINSHAW,G.L.ZIPP,M.J.RUWART, REMARK 1 AUTH 4 F.J.SCHWENDE,G.E.PADBURY,R.J.DALGA,W.-Z.ZHONG,L.SHIOU, REMARK 1 AUTH 5 P.L.POSSERT,BOB D.RUSH,KAREN F.WILKINSON,GINA M.HOWARD, REMARK 1 AUTH 6 L.N.TOTH,M.G.WILLIAMS,T.J.KAKUK,S.L.COLE,R.M.ZAYA, REMARK 1 AUTH 7 K.D.LOVASZ,J.K.MORRIS,K.R.ROMINES,S.THAISRIVONGS, REMARK 1 AUTH 8 P.A.ARISTOFF REMARK 1 TITL STRUCTURE-BASED DESIGN OF SULFONAMIDE-SUBSTITUTED REMARK 1 TITL 2 NON-PEPTIDIC HIV PROTEASE INHIBITORS. REMARK 1 REF J.MED.CHEM. V. 38 4968 1995 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 8544171 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CEDAR REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 82.9 REMARK 3 NUMBER OF REFLECTIONS : 7560 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1491 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 164 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1HPO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000173960. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-FEB-94 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 4.8-5.4, 5.0-5.6, 5.2-5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : SIEMENS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XENGEN REMARK 200 DATA SCALING SOFTWARE : XENGEN REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9119 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 10.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.13200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.5 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : 0.53400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MERLOT REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS WERE GROWN AT ROOM REMARK 280 TEMPERATURE IN 10 UL HANGING DROPS OF EQUAL VOLUMES OF PROTEIN/ REMARK 280 INHIBITOR COMPLEX AND THE PRECIPITANT OF 0.75, 1.0 1.5 2.0 M REMARK 280 NACL AT PH'S 4.8, 5.0 AND 5.2 (0.1 M ACETATE BUFFER) AND AT PH'S REMARK 280 5.4, 5.6 AND 5.8 (0.1 M CITRATE BUFFER)., VAPOR DIFFUSION - REMARK 280 HANGING DROP, PH 5.4, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 30.27150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.20800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.27150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.20800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4870 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9240 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 7 CD CE NZ REMARK 470 LYS A 14 CD CE NZ REMARK 470 ARG A 41 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 43 CG CD CE NZ REMARK 470 LYS B 7 CD CE NZ REMARK 470 LYS B 43 CD CE NZ REMARK 470 LYS B 70 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 61 80.22 32.37 REMARK 500 CYS A 67 80.26 32.03 REMARK 500 LEU B 5 36.13 -93.67 REMARK 500 CYS B 67 66.57 32.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNI B 100 DBREF 1HPO A 1 99 UNP P03367 POL_HV1BR 69 167 DBREF 1HPO B 1 99 UNP P03367 POL_HV1BR 69 167 SEQADV 1HPO LYS A 7 UNP P03367 GLN 75 ENGINEERED MUTATION SEQADV 1HPO ILE A 33 UNP P03367 LEU 101 ENGINEERED MUTATION SEQADV 1HPO ILE A 63 UNP P03367 LEU 131 ENGINEERED MUTATION SEQADV 1HPO LYS B 7 UNP P03367 GLN 75 ENGINEERED MUTATION SEQADV 1HPO ILE B 33 UNP P03367 LEU 101 ENGINEERED MUTATION SEQADV 1HPO ILE B 63 UNP P03367 LEU 131 ENGINEERED MUTATION SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 A 99 ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY CYS THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 B 99 ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY CYS THR LEU ASN PHE HET UNI B 100 36 HETNAM UNI 4-CYANO-N-(3-CYCLOPROPYL(5,6,7,8,9,10-HEXAHYDRO-4- HETNAM 2 UNI HYDROXY-2-OXO-CYCLOOCTA[B]PYRAN-3-YL)METHYL)PHENYL HETNAM 3 UNI BENZENSULFONAMIDE FORMUL 3 UNI C28 H28 N2 O5 S FORMUL 4 HOH *164(H2 O) HELIX 1 H1 GLY A 86 THR A 91 1 6 HELIX 2 H2 GLY B 86 THR B 91 1 6 SHEET 1 S1 4 PRO A 1 LEU A 5 0 SHEET 2 S1 4 CYS B 95 PHE B 99 -1 O LEU B 97 N ILE A 3 SHEET 3 S1 4 CYS A 95 PHE A 99 -1 O THR A 96 N ASN B 98 SHEET 4 S1 4 PRO B 1 LEU B 5 -1 O ILE B 3 N LEU A 97 SHEET 1 S2 2 PRO A 9 ILE A 15 0 SHEET 2 S2 2 GLN A 18 LEU A 24 -1 N LEU A 24 O PRO A 9 SHEET 1 S3 3 ALA A 22 LEU A 24 0 SHEET 2 S3 3 ASN A 83 GLY A 86 1 O ASN A 83 N LEU A 23 SHEET 3 S3 3 ASP A 30 VAL A 32 -1 N VAL A 32 O ILE A 84 SHEET 1 S4 3 LYS A 43 GLY A 48 0 SHEET 2 S4 3 GLY A 52 TYR A 59 -1 N ILE A 54 O ILE A 47 SHEET 3 S4 3 VAL A 75 VAL A 77 -1 O VAL A 75 N TYR A 59 SHEET 1 S5 2 PRO B 9 ILE B 15 0 SHEET 2 S5 2 GLN B 18 LEU B 24 -1 N LEU B 24 O PRO B 9 SHEET 1 S6 3 ALA B 22 LEU B 24 0 SHEET 2 S6 3 ASN B 83 GLY B 86 1 O ASN B 83 N LEU B 23 SHEET 3 S6 3 ASP B 30 VAL B 32 -1 N VAL B 32 O ILE B 84 SHEET 1 S7 3 LYS B 43 GLY B 48 0 SHEET 2 S7 3 GLY B 52 TYR B 59 -1 N ILE B 54 O ILE B 47 SHEET 3 S7 3 VAL B 75 VAL B 77 -1 O VAL B 75 N TYR B 59 SITE 1 AC1 17 ARG A 8 ASP A 25 GLY A 27 ALA A 28 SITE 2 AC1 17 GLY A 49 ILE A 50 ILE A 84 ASP B 25 SITE 3 AC1 17 GLY B 27 ALA B 28 ASP B 29 GLY B 48 SITE 4 AC1 17 GLY B 49 ILE B 50 ILE B 84 HOH B 302 SITE 5 AC1 17 HOH B 304 CRYST1 60.543 88.416 46.484 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016517 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011310 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021513 0.00000